Fetal growth as an integrated maternal-placental-fetal system: What evidence can explain

Fetal growth results from the dynamic interaction of maternal, placental, and fetal factors. Most accounts converge on a simple but sophisticated mechanism: maternal status regulates substrate availability, the placenta transports nutrients, and the fetus adapts to a tightly controlled environment. This review tests that framework against two things it usually leaves out: how well current biomarkers and Doppler models perform, and what historical evidence of severe maternal starvation reveals about how much fetal size depends on maternal intake. The performance gap is consistent. Biomarker- and Doppler-based models for fetal growth restriction (FGR) detect over 85% of early-onset cases but only 66% or fewer of late-onset ones, a gap current angiogenic and Doppler markers cannot fully close. Placental insufficiency, not maternal diet alone, drives most pathological FGR: histological signs of maternal vascular underperfusion appear in roughly two-thirds of growth-restricted placentas, often missed by antenatal Doppler. During the Dutch Hunger Winter and the siege of Leningrad, months of severe caloric deprivation reduced birth weight by only a few hundred grams, yet still correlated with raised adult metabolic disease risk. Birth weight, in short, is a poor proxy for the intrauterine stress a fetus actually experiences. Two rare endocrine syndromes, Laron syndrome and Guevara-Rosenbloom syndrome, separate what insulin-like growth factor 1 (IGF-1) and insulin signaling each contribute to fetal size and later metabolic risk. These findings point toward assessment models that report detection and false-positive rates by gestational timing, and that account for metabolic programming even when birth weight does not drop.